Acadia Pharmaceuticals ACAD Change in Inventories
Change in Inventories at other companies
Other financials
Where this comes from
Reported directly by Acadia Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:IncreaseDecreaseInInventories.
The official record: Acadia Pharmaceuticals’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Acadia Pharmaceuticals's change in inventories.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Acadia Pharmaceuticals's change in inventories?
- Acadia Pharmaceuticals (ACAD) reported change in inventories of -$78K in Q1 2026.
- How has Acadia Pharmaceuticals's change in inventories changed year-over-year?
- Acadia Pharmaceuticals's change in inventories decreased by 100.7% year-over-year, from $10.45M to -$78K.
- What is the long-term trend for Acadia Pharmaceuticals's change in inventories?
- Over 4 years (2021 to 2025), Acadia Pharmaceuticals's change in inventories has grown at a 44.8% compound annual growth rate (CAGR), from $4.43M to $19.45M.
- What does change in inventories mean?
- Increase or decrease in inventory levels, directly affecting operating cash flow and working capital.